Downregulation of sCD40 and sCTLA4 in Recovered COVID-19 Patients with Comorbidities
The aim of this study was to analyze molecules associated with regulatory immune response in unvaccinated, recovered COVID-19 patients with and without diabetes mellitus (DM) and hypertension (HTN). We determined anti-SARS-CoV-2 nucleocapsid IgG in plasma by electrochemiluminescence immunoassay. The...
Main Authors: | Gwendolyne Méndez-Frausto, Susana Godina-González, César E. Rivas-Santiago, Edna Nungaray-Anguiano, Gretel Mendoza-Almanza, Bruno Rivas-Santiago, Carlos E. Galván-Tejada, Irma E. Gonzalez-Curiel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/11/10/1128 |
Similar Items
-
sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence
by: Andrea Aprilia, et al.
Published: (2024-01-01) -
Co-inhibitory receptors in female asthmatic patients: Correlation with IL-17 and IL-26
by: Sabrine Louhaichi, et al.
Published: (2018-03-01) -
Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
by: Janina Świderska, et al.
Published: (2022-01-01) -
Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD
by: Rui Zhang, et al.
Published: (2022-06-01) -
PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS
by: hend Attia
Published: (2023-08-01)